SCHEMBL4546963

SCHEMBL4546963

Cc1ccc(-c2cc(-c3ccc(C)cc3)cc(-c3cc(-c4cccc(C)c4)nc(-c4cccc(C)c4)c3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
ENPP3 O14638 2/20 0.50
XDH P47989 1/20 0.47
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
IDO1 P14902 1/20 0.46
METAP2 P50579 1/20 0.46
RAB9A P51151 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
NPC1 O15118 1/20 0.44
AGTR1 P30556 1/20 0.44
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
DHODH Q02127 1/20 0.43
BCHE P06276 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4546979 0.98 MEN1 (0.57) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546983 0.94 ENPP3 (0.56) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL19216999 0.93 MEN1 (0.66) MEN1KMT2AENPP3KDM4EL3MBTL1
SCHEMBL4546978 0.93 MEN1 (0.56) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546880 0.92 ENPP3 (0.57) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546954 0.91 MEN1 (0.64) MEN1KMT2AENPP3KDM4EL3MBTL1
SCHEMBL4546994 0.91 MEN1 (0.54) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546977 0.91 MEN1 (0.54) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546995 0.91 MEN1 (0.54) MEN1KMT2AENPP3XDHKDM4E
SCHEMBL4546987 0.91 ENPP3 (0.51) MEN1KMT2AENPP3XDHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLCO4C1, SLCO2A1, SLCO2B1 MEN1 1984/4885KMT2A 1753/4885ENPP3 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.